XCUR Projected Dividend Yield
Exicure Inc ( NASDAQ : XCUR )Exicure is an early-stage biotechnology company developing nucleic acid therapies targeting ribonucleic acid against validated targets to neurological disorders and hair loss. Co. is focus on realignment of its research and development resources to support the development of its preclinical program targeting SCN9A for neuropathic pain; the development of its partnered programs to develop Spherical Nucleic Acid, or SNA-based treatments in neuroscience targeting Huntington's disease and Angelman syndrome; the development of its partnered program to develop SNA-based treatments for hair loss disorders; and the research and development of other undisclosed therapeutic product candidates. 20 YEAR PERFORMANCE RESULTS |
XCUR Dividend History Detail XCUR Dividend News XCUR Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |